The global aesthetic medicine market is projected to achieve substantial growth, reaching an estimated value of USD 304.82 billion by 2030, as indicated in “Aesthetic Medicine Market Share, Size, Trends, Industry Analysis Report, By Procedure, By End-Use, Segment Forecast, 2022 – 2030” As esteemed dermatologists, it is crucial to delve into the specifics of the current aesthetic medicine market dynamics and explore the factors driving future growth in our industry.
One of the key drivers of aesthetic medicine market revenue growth is the increasing number of patients opting for mastectomy, which subsequently fuels demand for cosmetic medical procedures. This trend is further bolstered by the continuous advancements in minimally invasive and non-invasive aesthetic solutions, capturing the attention of both practitioners and patients alike.
Developing nations are witnessing a surge in demand for aesthetic treatments, primarily attributed to the growing aspiration among individuals to maintain a youthful and fit appearance. Countries such as India and South Korea are witnessing a rise in consumers seeking procedures like liposuction, nose reshaping, and Botox injections.
The 2020 International Society of Aesthetic Plastic Surgery (ISAPS) report reveals that worldwide, there were 6,213,859 Botulinum Toxin procedures and 1,225,540 eyelid surgeries performed.
The COVID-19 pandemic had a significant impact on the market for aesthetic medicine, initially witnessing a decline in consumer income levels and a sharp reduction in demand for aesthetic products and services. Operational restrictions, temporary closure of beauty salons, and disruptions in the supply and manufacturing chains further contributed to short-term negative growth in the industry.
However, the industry has witnessed a notable recovery due to the swift outreach of doctors, healthcare providers (HCPs), patients, and stakeholders via social media and digital platforms. This increased communication has fostered greater acceptance of cosmetic medical procedures among the public.
Looking ahead, this enhanced communication and acceptance are expected to result in a greater demand for aesthetic medicine tools and products. Manufacturers catering to regional consumer needs, like India, which ranked among the top 5 countries globally for non-surgical procedures in the 2020 ISAPS report, will see promising opportunities in the market.
Key highlights from the aesthetic medicine market report:
- Non-invasive procedures dominate the revenue share, with the segment projected to experience the fastest CAGR growth during the forecast period. Factors such as reduced pain, quick results, and cost-effectiveness are driving the global interest in non-invasive treatments.
- Beauty centers are poised to capture a significant portion of the global market, benefiting from expanding facilities and growing consumer awareness of various skin conditions.
- Asia Pacific is expected to witness the fastest CAGR growth, fueled by countries like South Korea, China, and India. The region’s market growth is driven by the availability of technologically advanced products, increasing emphasis on appearance, and South Korea’s reputation as a hub for cosmetic surgery.
- The aesthetic medicine market is highly competitive due to the presence of major global players, including Allergan-AbbVie, Alma Laser